Kevin Church

Insider Reports History

Entity: Individual
Location: 4000 Mason Road, Suite 300, Box 352141, Seattle, WA
Signature: /s/ Mark Worthington, Attorney-in-Fact on behalf of Kevin Church
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Athira Pharma, Inc.	CHIEF SCIENTIFIC OFFICER	Restricted Stock Units	110K	$62.3K	$0.57	Oct 1, 2024	Direct
Athira Pharma, Inc.	CHIEF SCIENTIFIC OFFICER	Common Stock	92.7K	$52.5K	$0.57	Sep 5, 2024	Direct
Athira Pharma, Inc.	CHIEF SCIENTIFIC OFFICER	Stock Option (Right to Buy)	110K			Oct 1, 2024	Direct

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
ATHA	Athira Pharma, Inc.	Oct 1, 2024	2	$0	4	Oct 3, 2024	CHIEF SCIENTIFIC OFFICER
ATHA	Athira Pharma, Inc.	Sep 3, 2024	3	$5.21K	4	Sep 5, 2024	CHIEF SCIENTIFIC OFFICER
ATHA	Athira Pharma, Inc.	Feb 14, 2024	1	$0	4	Feb 16, 2024	CHIEF SCIENTIFIC OFFICER
ATHA	Athira Pharma, Inc.	Jan 4, 2024	4	-$517	4/A	Feb 16, 2024	CHIEF SCIENTIFIC OFFICER
ATHA	Athira Pharma, Inc.	Jan 4, 2024	4	-$517	4	Jan 8, 2024	Chief Scientific Officer
ATHA	Athira Pharma, Inc.	Mar 24, 2023	2	$8.65K	4	Mar 27, 2023	Chief Scientific Officer
ATHA	Athira Pharma, Inc.	Jan 19, 2023	2	$1.8K	4	Jan 23, 2023	Executive VP, Research
ATHA	Athira Pharma, Inc.	Oct 28, 2022	2	$5K	4	Oct 31, 2022	Executive VP, Research
ATHA	Athira Pharma, Inc.	Jun 22, 2022	2	-$7.03K	4	Jun 24, 2022	Executive VP, Research
ATHA	Athira Pharma, Inc.	Jun 8, 2022	3	$5.09K	4	Jun 10, 2022	Executive VP, Research
ATHA	Athira Pharma, Inc.	Feb 18, 2022	2	$3.75K	4	Feb 18, 2022	Executive VP, Research
ATHA	Athira Pharma, Inc.	Jan 18, 2022	2	$1.2K	4	Jan 20, 2022	Executive VP, Research
ATHA	Athira Pharma, Inc.	Jun 8, 2021	2	$3.28K	4	Jun 9, 2021	Vice President of Discovery
ATHA	Athira Pharma, Inc.	May 18, 2021	3	$5.95K	4/A	Jun 10, 2021	Vice President of Discovery